Prapid Tablet 5 mg contains Prasugrel Hydrochloride, a potent antiplatelet agent used to prevent blood clot formation in patients with acute coronary syndromes (ACS) who are undergoing percutaneous coronary intervention (PCI) or other high-risk cardiac procedures. Prasugrel belongs to the thienopyridine class of antiplatelet drugs and works by inhibiting platelet aggregation, reducing the risk of heart attack, stroke, or vascular complications in susceptible patients.

Prapid Tablet is particularly beneficial for patients with a history of unstable angina, myocardial infarction, or coronary artery stent placement, providing consistent antiplatelet effects that enhance cardiovascular outcomes when combined with standard therapy such as aspirin.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Prasugrel is a prodrug that is metabolized in the liver to its active form. It selectively and irreversibly inhibits the P2Y12 adenosine diphosphate (ADP) receptor on platelet surfaces. By blocking this receptor:

• Platelets are prevented from aggregating

• Formation of arterial thrombi is reduced

• Blood flow to the heart is maintained, minimizing ischemic events

The antiplatelet effect persists for the lifespan of the affected platelets, typically 7–10 days, ensuring prolonged protection against clot formation.

Indications

Prapid Tablet 5 mg is indicated for:

• Prevention of thrombotic cardiovascular events in patients with acute coronary syndromes, including:

  • Unstable angina

  • Non-ST-elevation myocardial infarction (NSTEMI)

  • ST-elevation myocardial infarction (STEMI)

• Adjunct therapy in patients undergoing PCI to prevent stent thrombosis

• Reduction of risk for stroke, heart attack, or cardiovascular death in high-risk patients

Prasugrel is often used in combination with low-dose aspirin to achieve dual antiplatelet therapy (DAPT), which is standard for patients undergoing PCI.

Dosage and Administration

• The usual maintenance dose is 5 mg orally once daily, or as prescribed by a cardiologist

• An initial loading dose may be administered in hospital settings prior to PCI for rapid antiplatelet action

• Tablets should be swallowed whole with water and taken consistently at the same time each day

• Regular monitoring for bleeding complications, platelet counts, and cardiovascular status is recommended

• Dose adjustments may be necessary in elderly patients or those with low body weight or renal impairment

Benefits of Prapid Tablet

• Provides effective antiplatelet therapy to prevent blood clots

• Reduces the risk of heart attack, stroke, and stent thrombosis

• Offers consistent and prolonged inhibition of platelet aggregation

• Can be combined with aspirin for dual antiplatelet therapy, enhancing protection in high-risk patients

• Supports better long-term cardiovascular outcomes in post-PCI and ACS patients

Possible Side Effects

Common side effects may include:

• Easy bruising or minor bleeding

• Nosebleeds or gum bleeding

• Nausea or mild gastrointestinal discomfort

• Headache or dizziness

Serious but rare side effects may include:

• Severe or uncontrolled bleeding (intracranial or gastrointestinal)

• Thrombocytopenia (low platelet count)

• Allergic reactions or rash

Patients should seek immediate medical attention if they experience unusual or severe bleeding.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

• Not recommended for patients with active bleeding, history of stroke, or intracranial hemorrhage

• Use cautiously in elderly patients or those weighing less than 60 kg

• Avoid use in patients with liver or kidney impairment without physician guidance

• Inform healthcare providers of all medications to avoid drug interactions, particularly with other antiplatelet or anticoagulant drugs

• Pregnancy and breastfeeding use only under strict medical supervision

Storage

Store below 25°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Prapid Tablet 5 mg offers effective antiplatelet therapy for high-risk cardiovascular patients, helping prevent clot formation and reduce the risk of heart attack, stroke, and stent-related complications under professional supervision.